3.28
price up icon1.23%   0.04
 
loading
Precedente Chiudi:
$3.24
Aprire:
$3.41
Volume 24 ore:
235.80K
Relative Volume:
0.51
Capitalizzazione di mercato:
$74.33M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-3.4894
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
-6.55%
1M Prestazione:
-36.31%
6M Prestazione:
-66.08%
1 anno Prestazione:
-23.19%
Intervallo 1D:
Value
$3.23
$3.41
Intervallo di 1 settimana:
Value
$3.18
$3.69
Portata 52W:
Value
$2.77
$12.23

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
209
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Compare XGN vs TMO, DHR, IDXX, A, WAT

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
3.28 73.43M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
504.82 191.54B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
212.58 151.94B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
629.35 49.28B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
125.81 35.32B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
323.37 31.37B 3.17B 642.63M 539.81M 10.77

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-11 Iniziato B. Riley Securities Buy
2025-07-30 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2025-07-23 Iniziato Craig Hallum Buy
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
Feb 13, 2026

Returns Recap: Can Exagen Inc maintain sales growthWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

How interest rate cuts could boost Exagen Inc. stockQuarterly Performance Summary & Trade Opportunity Analysis - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

What Analysts Think Is Changing The Story For Exagen (XGN) Now - Yahoo Finance

Feb 12, 2026
pulisher
Feb 11, 2026

Exagen Inc. (NASDAQ:XGN) Short Interest Down 67.3% in January - MarketBeat

Feb 11, 2026
pulisher
Feb 09, 2026

Aug EndMonth: Is NVMI exposed to political risk2025 Price Momentum & Daily Stock Trend Watchlist - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 08, 2026
pulisher
Feb 08, 2026

Trend Recap: Is Exagen Inc being accumulated by smart moneyWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

Performance Recap: Is HBANM a speculative investmentRecession Risk & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 07, 2026

Quarterly Earnings: Is Exagen Inc being accumulated by smart moneyJuly 2025 PostEarnings & Capital Efficient Trading Techniques - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 01, 2026

B. Riley Reaffirms Buy Rating for Exagen (NASDAQ:XGN) - Defense World

Feb 01, 2026
pulisher
Jan 31, 2026

Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 65.7% - MarketBeat

Jan 31, 2026
pulisher
Jan 30, 2026

B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com

Jan 30, 2026
pulisher
Jan 30, 2026

XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus

Jan 30, 2026
pulisher
Jan 30, 2026

Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat

Jan 30, 2026
pulisher
Jan 28, 2026

Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru

Jan 28, 2026
pulisher
Jan 27, 2026

What are Exagen Inc.’s recent SEC filings showingWeekly Gains Summary & Weekly Return Optimization Plans - mfd.ru

Jan 27, 2026
pulisher
Jan 27, 2026

How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance

Jan 27, 2026
pulisher
Jan 25, 2026

Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛

Jan 25, 2026
pulisher
Jan 19, 2026

Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 17, 2026

Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat

Jan 17, 2026
pulisher
Jan 15, 2026

Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm

Jan 15, 2026
pulisher
Jan 15, 2026

Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm

Jan 15, 2026
pulisher
Jan 14, 2026

Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Published on: 2026-01-13 10:11:31 - ulpravda.ru

Jan 13, 2026
pulisher
Jan 13, 2026

Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail

Jan 13, 2026
pulisher
Jan 12, 2026

How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance

Jan 12, 2026
pulisher
Jan 12, 2026

Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks

Jan 12, 2026
pulisher
Jan 12, 2026

Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada

Jan 12, 2026
pulisher
Jan 12, 2026

California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer

Jan 12, 2026
pulisher
Jan 11, 2026

Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus

Jan 11, 2026
pulisher
Jan 11, 2026

Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative

Jan 11, 2026
pulisher
Jan 11, 2026

Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph

Jan 11, 2026
pulisher
Jan 11, 2026

Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan

Jan 11, 2026
pulisher
Jan 09, 2026

Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How ImmunityBio Inc. stock trades before earningsJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is MIMI stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk High Reward Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda ru > 2026> Is BPYPO stock dividend yield sustainableMarket Risk Analysis & Fast Entry High Yield Tips - ulpravda.ru

Jan 08, 2026

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$206.87
price up icon 0.00%
diagnostics_research LH
$282.63
price up icon 1.63%
diagnostics_research MTD
$1,360.95
price up icon 0.22%
diagnostics_research IQV
$166.94
price down icon 1.13%
$206.23
price down icon 0.77%
diagnostics_research WAT
$323.37
price up icon 1.11%
Capitalizzazione:     |  Volume (24 ore):